BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9698837)

  • 1. Serotypes of Vibrio cholerae non-O1 isolated from water supplies for human consumption in Campeche, México and their antibiotic susceptibility pattern.
    Isaac-Márquez AP; Lezama-Dávila CM; Eslava-Campos C; Navarro-Ocaña A; Cravioto-Quintana A
    Mem Inst Oswaldo Cruz; 1998; 93(1):17-22. PubMed ID: 9698837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes.
    Dalsgaard A; Forslund A; Bodhidatta L; Serichantalergs O; Pitarangsi C; Pang L; Shimada T; Echeverria P
    Epidemiol Infect; 1999 Apr; 122(2):217-26. PubMed ID: 10355785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of Vibrio spp. in drinking water and environmental samples in Vellore South India.
    Thomson CJ; Jesudason MV; Balaji V; Malathi B; Mukundan U; Amyes SG
    Epidemiol Infect; 1998 Aug; 121(1):67-76. PubMed ID: 9747757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.
    Sciortino CV; Johnson JA; Hamad A
    J Clin Microbiol; 1996 Apr; 34(4):897-900. PubMed ID: 8815104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
    Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
    Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriological profile of cholera in Tamil Nadu (1980-2001).
    Sundaram SP; Revathi J; Sarkar BL; Bhattacharya SK
    Indian J Med Res; 2002 Dec; 116():258-63. PubMed ID: 12807153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup.
    Mukhopadhyay AK; Garg S; Nair GB; Kar S; Ghosh RK; Pajni S; Ghosh A; Shimada T; Takeda T; Takeda Y
    Epidemiol Infect; 1995 Dec; 115(3):427-34. PubMed ID: 8557074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
    Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP
    PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio cholerae non-O1 as a causal pathogen in cholera patients in Yangon, Myanmar.
    Oo KN; Than WM; Win T; Thida M; Aung KS
    J Diarrhoeal Dis Res; 1995 Sep; 13(3):176-9. PubMed ID: 8568194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of virulence factors in Vibrio cholerae isolated from Iraq during the 2007-2009 outbreak.
    Saleh TH; Sabbah MA; Jasem KA; Hammad ZN
    Can J Microbiol; 2011 Dec; 57(12):1024-31. PubMed ID: 22133188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-O1/non-O139 Vibrio cholerae carrying multiple virulence factors and V. cholerae O1 in the Chesapeake Bay, Maryland.
    Ceccarelli D; Chen A; Hasan NA; Rashed SM; Huq A; Colwell RR
    Appl Environ Microbiol; 2015 Mar; 81(6):1909-18. PubMed ID: 25556194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistant Vibrio cholerae O1 from clinical and environmental samples in Kathmandu city.
    Thapa Shrestha U; Adhikari N; Maharjan R; Banjara MR; Rijal KR; Basnyat SR; Agrawal VP
    BMC Infect Dis; 2015 Feb; 15():104. PubMed ID: 25888391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic and genotypic characterization of Vibrio cholerae O1].
    Giono-Cerezo S; Rodríguez Angeles MG; Gutiérrez-Cogco L; Valdespino-Gómez JL
    Rev Latinoam Microbiol; 1994; 36(4):243-51. PubMed ID: 7701133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Vibrio cholerae O1 and non-O1 from human and environmental sources in Malaysia.
    Radu S; Ho YK; Lihan S; Yuherman ; Rusul G; Yasin RM; Khair J; Elhadi N
    Epidemiol Infect; 1999 Oct; 123(2):225-32. PubMed ID: 10579441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The emergence of multiple antimicrobial resistance in Vibrio cholerae isolated from gastroenteritis patients in Ceará, Brazil].
    Hofer E; Quintaes BR; dos Reis EM; Rodrigues Ddos P; Seki LM; Feitosa IS; Ribeiro LH; Ferreira MR
    Rev Soc Bras Med Trop; 1999; 32(2):151-6. PubMed ID: 10228365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and molecular characterization of Vibrio cholerae O1, non-O1 and non-O139 in tropical seafood in Cochin, India.
    Kumar R; Lalitha KV
    Foodborne Pathog Dis; 2013 Mar; 10(3):278-83. PubMed ID: 23489050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana.
    Abana D; Gyamfi E; Dogbe M; Opoku G; Opare D; Boateng G; Mosi L
    BMC Infect Dis; 2019 Jan; 19(1):76. PubMed ID: 30665342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa.
    Finch MJ; Morris JG; Kaviti J; Kagwanja W; Levine MM
    Am J Trop Med Hyg; 1988 Nov; 39(5):484-90. PubMed ID: 3195696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.